PHI at Aktieportföljen Live, BioStock and Financial Stockholm

December 12, 2024

The subscription period in Phase Holographic Imaging PHI AB’s (“PHI” or the “Company”) fully secured rights issue, totalling SEK 64.3 million, is ongoing until 20 December 2024. The Company’s CEO, Anders Månsson, has during the last couple of weeks presented the Company and its future plans at BioStock, Aktieportföljen Live and Financial Stockholm. Månsson has also been interviewed by the podcast Fill or Kill, to give more insight to the Company and its market potential. For links to the presentations and the podcast, see below.

Prospectus and how to subscribe

The subscription period runs until 20 December 2024. A prospectus containing more information about PHI and the rights issue is available on the Company’s website, www.phiab.com, on Spotlight Stock Market’s website, www.spotlightstockmarket.com as well as on Nordic Issuing AB’s website, www.nordic-issuing.se. Those interested in subscribing for shares in the rights issue should contact their banks for details on deadlines (since these may vary between banks) and instructions or visit www.nordic-issuing.se.

Advisors

Navia Corporate Finance AB is the financial advisor and Sole Bookrunner in connection with the rights issue. HWF Advokater AB is the legal advisor. Nordic Issuing AB is the issuing agent.

For more information about the rights issue, please contact:
Navia Corporate Finance AB
E-mail: info@naviacf.se
Website: www.naviacorporatefinance.com

For additional information, please contact:
Anders Månsson
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis

Subscribe to PHI news on cision.com